AU2002235788A1 - Detection of advanced glycation endproducts in a cerebrospinal fluid sample - Google Patents

Detection of advanced glycation endproducts in a cerebrospinal fluid sample

Info

Publication number
AU2002235788A1
AU2002235788A1 AU2002235788A AU3578802A AU2002235788A1 AU 2002235788 A1 AU2002235788 A1 AU 2002235788A1 AU 2002235788 A AU2002235788 A AU 2002235788A AU 3578802 A AU3578802 A AU 3578802A AU 2002235788 A1 AU2002235788 A1 AU 2002235788A1
Authority
AU
Australia
Prior art keywords
cerebrospinal fluid
detection
advanced glycation
fluid sample
glycation endproducts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002235788A
Inventor
Peter Stahl
Herbert Von Der Eltz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROSEMARIE KIENTSCH ENGEL
Original Assignee
ROSEMARIE KIENTSCH ENGEL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00127948A external-priority patent/EP1217378A1/en
Application filed by ROSEMARIE KIENTSCH ENGEL filed Critical ROSEMARIE KIENTSCH ENGEL
Publication of AU2002235788A1 publication Critical patent/AU2002235788A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Methods for measurement of at least one advanced glycation endproduct (AGE) in a cerebrospinal fluid (CSF) sample and use of these methods in the assessment of neurodegenerative disease.
AU2002235788A 2000-12-21 2001-12-18 Detection of advanced glycation endproducts in a cerebrospinal fluid sample Abandoned AU2002235788A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00127948A EP1217378A1 (en) 2000-12-21 2000-12-21 Detection of advanced glycation endproducts in a cerebrospinal fluid sample
EP00127948 2000-12-21
EP01102826 2001-02-13
EP01102826 2001-02-13
PCT/EP2001/014963 WO2002050548A1 (en) 2000-12-21 2001-12-18 Detection of advanced glycation endproducts in a cerebrospinal fluid sample

Publications (1)

Publication Number Publication Date
AU2002235788A1 true AU2002235788A1 (en) 2002-07-01

Family

ID=26071677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002235788A Abandoned AU2002235788A1 (en) 2000-12-21 2001-12-18 Detection of advanced glycation endproducts in a cerebrospinal fluid sample

Country Status (7)

Country Link
US (1) US20040126821A1 (en)
EP (1) EP1346227B1 (en)
JP (1) JP2004516027A (en)
AT (1) ATE270434T1 (en)
AU (1) AU2002235788A1 (en)
DE (1) DE60104143D1 (en)
WO (1) WO2002050548A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108776131B (en) * 2018-03-19 2020-06-09 深圳市南山区疾病预防控制中心 Method for detecting AGEs content in food
JP7546262B2 (en) * 2019-02-21 2024-09-06 国立研究開発法人農業・食品産業技術総合研究機構 Alzheimer's disease diagnosis technology

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
JPH09511492A (en) * 1994-02-03 1997-11-18 ザ ピコワー インスティテュート フォア メディカル リサーチ Compositions and methods for advanced glycosylation end product mediated modulation of amyloidosis
US5610076A (en) * 1994-04-29 1997-03-11 Alteon Inc. Method for detecting hemoglobin advanced glycosylation endproducts

Also Published As

Publication number Publication date
ATE270434T1 (en) 2004-07-15
US20040126821A1 (en) 2004-07-01
DE60104143D1 (en) 2004-08-05
WO2002050548A1 (en) 2002-06-27
EP1346227A1 (en) 2003-09-24
JP2004516027A (en) 2004-06-03
EP1346227B1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
WO2005060696A3 (en) Methods and apparatus for enhanced ion based sample detection using selective pre-separation and amplification
AU8058798A (en) Method and device for detecting or quantifying carbohydrate containing compounds
PL356578A1 (en) Method of determining the volume of biological sample, method o providing compensation for improper sample size, method of measuring at least one property of such sample, system for determining the volume of biological sample and system combined with a meter adapted for switching on its associated electrochemical cell and for measuring the concentration of one or more of selected analytes in such biological sample
WO2005067582A3 (en) Methods and apparatus for enhanced sample identification based on combined analytical techniques
EP2267136A3 (en) Glyphosate tolerant alfalfa events and methods for detection thereof
PL355789A1 (en) Device for determining concentration of at least one analyte, in particular that in the form of an indicator strip as we as method of making an element carrying such devices, in particular those in the form of an indicator strip and method of determining concentration of at least one analyte
WO2001036966A3 (en) An apparatus for machine fluid analysis
AU2002230650A1 (en) Method for diagnosing pathology in biological samples
WO2007102842A3 (en) Systems and methods for processing analyte sensor data
AU2001280265A1 (en) Navigation tool
DE60136292D1 (en) MULTI-ARRAY SYSTEM FOR INTEGRATING BIOARRAYS
AU2001292959A1 (en) Highly sensitive proteomic analysis methods and kits and systems for practicing the same
WO2002059575A3 (en) Method and apparatus for analysis of biological solutions
WO2001098542A3 (en) Universal collection medium
AU2003211060A1 (en) Systems and methods for flow detection and measurement in csf shunts
EP2312312A3 (en) Detection of conformationally altered proteins and prions
WO2002103323A3 (en) Microfluidic systems with enhanced detection systems
AU2002364120A1 (en) Sensor for the use in testing biological chemical or environmental samples
WO2004057341A3 (en) Cvd assay
WO2004077060A3 (en) Assay for detection of renal cell carcinoma
WO2001086285A3 (en) Direct detection of individual molecules
AU3498200A (en) An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
IL152281A0 (en) Device and method for measuring magnetic field(s) with calibration superimposed on the measurement, and corresponding uses
MX9706437A (en) Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds.
WO2008072275A3 (en) Telematic system for using diagnostic reagent strips and method for acquiring calibration data